lynestrenol has been researched along with Primary Myelofibrosis in 1 studies
Lynestrenol: A synthetic progestational hormone used often in mixtures with estrogens as an oral contraceptive (CONTRACEPTIVES, ORAL).
Primary Myelofibrosis: A de novo myeloproliferation arising from an abnormal stem cell. It is characterized by the replacement of bone marrow by fibrous tissue, a process that is mediated by CYTOKINES arising from the abnormal clone.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schmid, KO | 1 |
| Dapunt, O | 1 |
1 other study available for lynestrenol and Primary Myelofibrosis
| Article | Year |
|---|---|
[Atypical organ-oriented effects of so-called ovulation inhibitors following bilateral nephrectomy, as well as unusual endometrial changes during long-term acyclinc therapy for chronicmyelosis].
Topics: Adrenal Gland Diseases; Adult; Breast; Chemical and Drug Induced Liver Injury; Contraceptives, Oral; | 1968 |